Generalized serpiginous eruption during immunosuppressive treatment for leprosy reactive neuritis.
Division of Dermatology, Department of Internal Medicine, University of Sao Paulo, Ribeirao Preto, Brazil. cwambier@usp.br
Carlos Gustavo
CG
Wambier
Fernanda Britta Maitto
FB
Lemos
Mark Aaron
MA
Cappel
Fernando
F
Bellissimo-Rodrigues
Norma Tiraboschi
NT
Foss
D000818:Animals; D005076:Exanthema / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D015441:Leprosy, Tuberculoid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009443:Neuritis / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000139:chemically induced; D012867:Skin / Q000473:pathology; D017171:Strongyloides stercoralis / Q000302:isolation & purification*; D013322:Strongyloidiasis / Q000139:chemically induced*
D007166:Immunosuppressive Agents